Zanubrutinib, Lenalidomide and Rituximab (ZR2) in Elderly Treatment-naive Patients With Diffuse Large B-cell Lymphoma (DLBCL)
Clinical trial NCT04460248 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04460248
- Sponsor
- Ruijin Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-26
- Primary completion
- 2022-02-16
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.